Mahindra Group Chairman Anand Mahindra has shared his thoughts on Blindsight, Elon Musk's new idea to restore vision in the blind.

In a post on X, Mahindra said that Blindsight which is being built by Musk's Neuralink will be the "most enduring gift to humankind," if it is successful in doing what it is meant to do.

The industrialist even said that Neuralink could prove to be more revolutionary than Musk's car company Tesla and aerospace firm SpaceX.

"If this device lives up to these expectations then, much more than Tesla or Space X, THIS will be your most enduring gift to humankind," Mahindra replied on Musk's X post introducing Blindsight.

Many agreed with the industrialist saying the success of the Blindsight device could truly be revolutionary.

"So true. He will be remembered for this if neuralink actually achieves this feat," said a user. "Best gift to humanity. Also if it reaches its full potential, then someone with this device might have a big advantage over those not having it," wrote another.

ALSO SEE: Musk Claims Neuralink's Breakthrough Blindsight Device Will Soon Restore Vision In People Who Are Born Blind

What is the Blindsight device?

The Blindsight device, according to Musk, will enable those who have lost both their eyes and their optic nerve to see. It could also restore vision in those who have been blind since birth.

Musk said that the device will work as long as the visual cortex is intact in the patient. The coolest part is that the device will allow its patient to see in infrared, ultraviolet or even radar wavelengths, which are invisible to a normal human eye.

"To set expectations correctly, the vision will be at first low resolution, like Atari graphics, but eventually it has the potential be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths, like Geordi La Forge," Musk wrote.

Neuralink announced on September 18 that Blindsight has received the 'Breakthrough Device Designation' from the Food and Drug Administration. This will enable the company to move forward with Blindsight's development but it is unclear when the first human trials will take place.

ALSO SEE: Neuralink's First Patient Is Using The Brain Chip To Learn French And Japanese; 'Having A Blast'